{
    "clinical_study": {
        "@rank": "161592", 
        "acronym": "BTCOPD", 
        "arm_group": [
            {
                "arm_group_label": "Bosentan", 
                "arm_group_type": "Experimental", 
                "description": "Bosentan,125mg,po,bid combined with inhaled Symbicort turbuhaler, 320/9\u03bcg, bid."
            }, 
            {
                "arm_group_label": "Control", 
                "arm_group_type": "Active Comparator", 
                "description": "Inhaled Symbicort turbuhaler, 320/9\u03bcg, bid."
            }
        ], 
        "brief_summary": {
            "textblock": "Present treatment for chronic obstructive pulmonary disease (COPD) has a certain role in\n      reducing COPD exacerbation and hospitalization, improving the life quality, and postponing\n      the lung function decline. But for some patients with severe COPD, current treatment only\n      partially alleviates the symptoms and has little role in the lung function decline. In this\n      randomized, multicenter study, the investigators evaluate the safety and efficacy of\n      bosentan in the treatment of grade \u2162 or \u2163 COPD patients with pulmonary hypertension detected\n      by echocardiography. The primary endpoint is the frequency of COPD exacerbation, and the\n      secondary endpoint includes changes of lung function, 6-min-walk distance (6-MWD), SGRQ\n      score and mMRC/CAT score."
        }, 
        "brief_title": "Study of Bosentan in the Treatment of Stable Severe Chronic Obstructive Pulmonary Disease Patients", 
        "condition": "Chronic Obstructive Pulmonary Disease (COPD)", 
        "condition_browse": {
            "mesh_term": [
                "Lung Diseases", 
                "Respiration Disorders", 
                "Pulmonary Disease, Chronic Obstructive", 
                "Lung Diseases, Obstructive"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Aged 18 to 75\n\n          -  Gold \u2162 or \u2163 stable COPD\n\n          -  Pulmonary hypertension detected by echocardiography\n\n        Exclusion Criteria:\n\n          -  Acute exacerbation of chronic obstructive pulmonary disease\n\n          -  Untreated obstructive sleep apnea\n\n          -  Restrictive (total lung capacity<60% predicted) lung disease\n\n          -  Portal hypertension\n\n          -  Chronic liver disease\n\n          -  Transaminase increased to normal line more than 3 times; total bilirubin increased 2\n             times more than the upper limit of the normal value\n\n          -  Left-sided or unrepaired congenital heart disease\n\n          -  Patients with other serious heart diseases\n\n          -  Patients with 1, 2, 4 and 5 categories of pulmonary hypertension\n\n          -  Unable to complete the 6 minutes walk test\n\n          -  Patients receiving other endothelin receptor antagonists\n\n          -  No cooperation to complete"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "75 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "40", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 18, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02093195", 
            "org_study_id": "BTCOPD-2014226"
        }, 
        "intervention": [
            {
                "arm_group_label": "Bosentan", 
                "intervention_name": "Bosentan", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": [
                    "Bosentan", 
                    "Control"
                ], 
                "intervention_name": "Symbicort turbuhaler", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Bosentan", 
                "Symbicort", 
                "Budesonide"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": "Treatment, COPD, bosentan", 
        "lastchanged_date": "March 18, 2014", 
        "location": [
            {
                "contact": {
                    "email": "hxp0728@163.com", 
                    "last_name": "Xinpeng Han, MD", 
                    "phone": "+86-29-84771135"
                }, 
                "facility": {
                    "address": {
                        "city": "Xi'an", 
                        "country": "China", 
                        "state": "Shaanxi", 
                        "zip": "710032"
                    }, 
                    "name": "The department of pulmonary and critical care medicine, Xijing hospital"
                }, 
                "investigator": {
                    "last_name": "Xinpeng Han, MD", 
                    "role": "Sub-Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "liuyuan@xjtu.edu.cn", 
                    "last_name": "YUAN LIU, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Xi'an", 
                        "country": "China", 
                        "state": "Shaanxi", 
                        "zip": "710004"
                    }, 
                    "name": "The second affiliated hospital of xi'an jiaotong university"
                }, 
                "investigator": {
                    "last_name": "YUAN LIU, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "18542705@qq.com", 
                    "last_name": "LINGBIN XU, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Xi'an", 
                        "country": "China", 
                        "state": "Shaanxi", 
                        "zip": "710068"
                    }, 
                    "name": "Shaanxi Provincial People'S Hospital"
                }, 
                "investigator": {
                    "last_name": "LINGBIN XU, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "ting liu, MD", 
                    "phone": "18991938962"
                }, 
                "facility": {
                    "address": {
                        "city": "Xian", 
                        "country": "China", 
                        "state": "Shaanxi", 
                        "zip": "710064"
                    }, 
                    "name": "The first affiliated hospital of xi'an jiaotong university"
                }, 
                "investigator": {
                    "last_name": "TING LIU, MD", 
                    "role": "Sub-Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "13709205538@163.com", 
                    "last_name": "yandong nan, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Xian", 
                        "country": "China", 
                        "state": "Shaanxi", 
                        "zip": "710038"
                    }, 
                    "name": "The department of pulmonary and critical care medicine, Tangdou hospital"
                }, 
                "investigator": {
                    "last_name": "YANDONG NAN, MD", 
                    "role": "Sub-Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_arms": "2", 
        "official_title": "Phase \u2161 Study of Bosentan in the Treatment of Stable Severe Chronic Obstructive Pulmonary Disease Patients", 
        "overall_contact": {
            "email": "shengqingli@gmail.com", 
            "last_name": "Shengqing Li, MD, PhD", 
            "phone": "+86-29-84771132"
        }, 
        "overall_official": {
            "affiliation": "The department of pulmonary and critical care medicine, Xijing hospital", 
            "last_name": "Shengqing Li, MD, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "China: Food and Drug Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Frequency of COPD Exacerbation", 
            "safety_issue": "No", 
            "time_frame": "12 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02093195"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Fourth Military Medical University", 
            "investigator_full_name": "Shengqing Li", 
            "investigator_title": "Associate Chief Physician, Associate Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "6-min-walk distance (6-MWD)", 
                "safety_issue": "No", 
                "time_frame": "12 months"
            }, 
            {
                "measure": "Lung Function", 
                "safety_issue": "No", 
                "time_frame": "12 months"
            }, 
            {
                "measure": "mMRC/CAT score", 
                "safety_issue": "No", 
                "time_frame": "12 months"
            }, 
            {
                "measure": "SGRQ score", 
                "safety_issue": "No", 
                "time_frame": "12 months"
            }
        ], 
        "source": "Fourth Military Medical University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Fourth Military Medical University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}